US Stock MarketDetailed Quotes

RSLS ReShape Lifesciences

Watchlist
  • 5.9400
  • +0.1900+3.30%
Close Nov 29 13:00 ET
  • 5.5741
  • -0.3659-6.16%
Post 17:02 ET
4.23MMarket Cap-592P/E (TTM)

ReShape Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ReShape Lifesciences Q3 2024 Earnings Date

Currency：USDNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
2.29M
--
+6.36%
EPS
--
-3.11
--
+94.76%
Analyst Rating
No Data

ReShape Lifesciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 15, 20242024/Q11.944M / 2.104M--
--2023/Q41.982M / 2.208M--
Nov 8, 20232023/Q32.155M / 2.400M--
Aug 7, 20232023/Q22.254M / 2.610M--
May 15, 20232023/Q12.287M / 2.513M--
DatePeriodRevenue/EstimateEarnings Call
May 15, 20242024/Q11.944M / 2.104M--
--2023/Q41.982M / 2.208M--
Nov 8, 20232023/Q32.155M / 2.400M--
Aug 7, 20232023/Q22.254M / 2.610M--
May 15, 20232023/Q12.287M / 2.513M--

Unlock Free Earnings Estimates

ReShape Lifesciences Earnings Reports

  • ReShape Lifesciences | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:36 ET

  • ReShape Lifesciences | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:36 ET

  • ReShape Lifesciences | 10-Q: Q1 2024 Earnings Report

    May 15 16:56 ET

  • ReShape Lifesciences | 10-K: FY2023 Annual Report

    Apr 1 17:25 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data